UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2024

 

Or

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to ______

 

Commission file number 333-143630

 

BORN, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   20-4682058

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

  

50 West Liberty Street, Suite 880    
Reno, Nevada   89501
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (646) 768-8417

 

N/A
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☐ Yes ☒ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated Filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.) Yes No ☐

 

As of January 13, 2025 the Registrant had 419,984,423 shares of Common Stock issued and outstanding.

 

 

 

 

 

 

BORN, INC.

QUARTERLY REPORT ON FORM 10-Q

For the Three and Six Months Ended June 30, 2024 and 2023

 

Part I – FINANCIAL INFORMATION 1
     
Item 1. Condensed Financial Statements (unaudited) 2
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 13
     
Item 4. Controls and Procedures 13
     
Part II – OTHER INFORMATION 15
     
Item 1. Legal Proceedings 15
     
Item 1A. Risk Factors 15
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 15
     
Item 3. Defaults Upon Senior Securities 15
     
Item 4. Mine Safety Disclosures 15
     
Item 5. Other Information 15
     
Item 6. Exhibits 15
     
SIGNATURES 16

 

i

 

 

PART I – FINANCIAL INFORMATION

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Information contained in this quarterly report on Form 10-Q contains “forward-looking statements.” These forward-looking statements are contained principally in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project” or the negative of these words or other variations on these words or comparable terminology. The forward-looking statements herein represent our expectations, beliefs, plans, intentions or strategies concerning future events, including, but not limited to: our ability to consummate the Merger, as such term is defined below; our future financial performance; the continuation of historical trends; the sufficiency of our resources in funding our operations; our intention to engage in mergers and acquisitions; and our liquidity and capital needs. Our forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that any projections or other expectations included in any forward-looking statements will come to pass. Moreover, our forward-looking statements are subject to various known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. These risks, uncertainties and other factors include but are not limited to: the risks of limited management, labor, and financial resources; our ability to establish and maintain adequate internal controls; our ability to develop and maintain a market in our securities; and our ability obtain financing, if and when needed, on terms that are acceptable. Except as required by applicable laws, we undertake no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.

 

As used in this quarterly report on Form 10-Q, “we”, “our”, “us” and the “Company” refer to Born, Inc. a Nevada corporation unless the context requires otherwise.

 

1

 

 

Item 1. Condensed Financial Statements.

 

Index to Condensed Financial Statements

 

    Page
CONDENSED FINANCIAL STATEMENTS:    
     
Condensed Balance Sheets, June 30, 2024 (unaudited), and December 31, 2023   3
     
Unaudited Condensed Statements of Operations for the Three and Six Months Ended June 30, 2024, and June 30, 2023   4
     
Unaudited Condensed Statements of Changes in Stockholders’ Deficit for the Three and Six Months Ended June 30, 2024, and 2023   5
     
Unaudited Condensed Statements of Cash Flows for the Three and Six Months Ended June 30, 2024, and 2023   6
     
Notes to the Unaudited Condensed Interim Financial Statements   7

 

2

 

 

BORN, INC.

BALANCE SHEETS

 

   June 30,   December 31, 
   2024   2023 
   (Unaudited)     
ASSETS        
         
Total Assets  $
     -
   $
-
 
           
LIABILITIES & STOCKHOLDERS’ DEFICIT          
           
Accounts payable   16,816    14,440 
Related party payables   17,411    15,677 
Current liabilities   34,227    30,117 
Total liabilities   34,227    30,117 
    -      
Stockholders’ Deficit   -      
Preferred stock, par value $.001, 10,000,000 shares authorized, 10,000,000 issued   -      
and outstanding as of June 30, 2024 and December 31, 2023 respectively   10,000    10,000 
Common stock, Par Value $.001, 500,000,000 shares authorized, 419,984,423 and 419,984,423 issued and outstanding of shares as of June 30, 2024 and December 31, 2023, respectively   419,985    419,985 
Additional paid in capital   117,017,022    117,017,022 
Accumulated deficit   (117,481,233)   (117,477,124)
Total Stockholders’ (Deficit)   (34,227)   (30,117)
Total Liabilities and Stockholders’ Deficit  $
-
   $
-
 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

 

BORN, INC.

STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three months   Three months   Six months   Six months 
   ended   ended   ended   ended 
   June 30,   June 30,   June 30,   June 30, 
   2024   2023   2024   2023 
Revenue 
 
  
 
         
                 
Operating Expenses:                
Administrative expenses  $2,293   $5,188   $4,110   $7,376 
Total operating expenses   2,293    5,188    4,110    7,376 
(Loss) from operations   (2,293)   (5,188)   (4,110)   (7,376)
Other (expense) income                    
Other (expense) net   
-
    
-
    
-
    
-
 
Income (loss) before provision for income taxes   (2,293)   (5,188)   (4,110)   (7,376)
Provision for income taxes   
-
    
-
    
-
    
-
 
Net (Loss)   (2,293)   (5,188)   (4,110)   (7,376)
                     
Basic and diluted loss per common share  $(0.00)  $(0.00)  $(0.00)  $(0.00)
                     
Weighted average number of shares outstanding   419,763,612    419,763,612    419,763,612    419,763,612 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

BORN, INC.

STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(Unaudited)

 

                   Additional       Total 
   Preferred Stock   Common Stock   Paid-in   Accumulated   Stockholders’ 
   Shares   Value   Shares   Value   Capital   Deficit   Equity 
Balance, December 31, 2022   10,000,000   $10,000    419,763,612   $419,985   $117,017,022   $(117,455,902)  $     (8,896)
                                    
Net loss                            (2,188)   (2,188)
                                    
Balance, March 31, 2023   10,000,000   $10,000    419,763,612   $419,985   $117,017,022   $(117,458,090)  $(11,084)
                                    
Net loss                            (5,188)   (5,188)
                                    
Balance, June 30, 2023   10,000,000   $10,000    419,763,612   $419,985   $117,017,022   $(117,463,278)  $(16,272)
                                    
   Preferred Stock   Common Stock   Paid-in   Accumulated   Stockholders’ 
   Shares   Value   Shares   Value   Capital   Deficit   Equity 
Balance, December 31, 2023   10,000,000   $10,000    419,763,612   $419,985   $117,017,022   $(117,477,124)  $(30,117)
                                    
Net loss                            (1,817)   (1,817)
                                    
Balance, March 31, 2024   10,000,000   $10,000    419,763,612   $419,985   $117,017,022   $(117,478,941)  $(31,934)
                                    
Net loss                            (2,293)   (2,293)
                                    
Balance, June 30, 2024   10,000,000   $10,000    419,763,612   $419,985   $117,017,022   $(117,481,234)  $(34,227)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

5

 

 

BORN, INC.

STATEMENTS OF CASH FLOWS

(Unaudited)

 

   Six months   Six months 
   ended   ended 
   June 30,   June 30, 
   2024   2023 
Cash Flows From Operating Activities:        
Net (loss)  $(4,110)  $(7,376)
Changes in operating assets and liabilities:          
Accounts payable and accrued expenses   2,376    2,376 
Net cash (used in) operating activities   (1,734)   (5,000)
           
Cash Flows From Investing Activities:          
Net cash provided by (used in) investing activities   
-
    
-
 
           
Cash Flows From Financing Activities:          
Proceeds from related party loans   1,734    5,000 
Net cash provided by financing activities   1,734    5,000 
           
Net Increase (Decrease) In Cash   
-
    
-
 
Cash At The Beginning Of The Period   
-
    
-
 
Cash At The End Of The Period  $
-
   $
-
 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

6

 

 

BORN, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED

JUNE 30, 2024 AND JUNE 30, 2023

 

 

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Born, Inc. f/k/a “Quture International, Inc. (“Born”, “we”, “us”, or, the “Company”), is a Nevada corporation, formed in April 2011 to become an emerging healthcare knowledge solution company created to transform health and healthcare by developing the standard in measuring clinical performance and outcomes. The Company developed medical software with tools and analytics intended to reduce costs while improving clinical performance, outcomes, predictive insight, and evidence-based best clinical processes.

 

On August 10, 2011, holders of a majority of the Registrant’s outstanding Common Stock voted to amend the Registrant’s Articles of Incorporation to increase the number of its authorized shares of capital stock from 900,000,000 shares to 2,510,000,000 par value $0.001 shares (the “Amendment”) of which (a) 2,500,000,000 shares were designated as Common Stock and (b) 10,000,000 shares were designated as blank check preferred stock.

 

During the period from March 22, 2013, through December 26, 2019, the Company was dormant.

 

On December 27, 2019, Custodian Ventures, LLC, an entity controlled by David Lazar, was appointed by the Nevada Court as the custodian of Quture. On December 31, 2019, Mr. Lazar became the only Director and Officer of the Company also acting as its President, Treasurer, and Secretary.

 

On April 5, 2020, the Company granted Mr. Lazar 10,000,000 preferred shares with super-voting rights of 21,000,000,000 common shares.

 

On September 10, 2020, the Company filed a Certificate of Designation with the State of Nevada changing the conversion and voting rights of the Company’s Series A preferred stock, $.001 par value per share to 250 for each one (1) share of Series A preferred stock.

 

On September 23, 2020, as a result of a private transaction, 10,000,000 shares of Series A Convertible Preferred Stock, $0.001 par value per share (the “Shares”) of the Company were transferred from Custodian Ventures, LLC (the “Seller”) to FiveT Capital Holding AG (the “Purchaser”). As a result, the Purchaser became an approximately 50.2% holder of the voting rights of the issued and outstanding share capital of the Company on a fully-diluted basis of the Company and became the controlling shareholder. In connection with the transaction, David Lazar released the Company from all debts owed to him and/or the Seller.

 

On September 23, 2020, the existing director and officer resigned immediately. Accordingly, David Lazar, serving as a director and an officer, ceased to be the Company’s Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary, and Director.

 

On November 24, 2020, Quture International, Inc. amended its articles of incorporation to change its name to Born, Inc. (the “Name Change”). The change was made in anticipation of entering into a new line of business operations.

 

Also on November 24, 2020, the Company amended its articles of incorporation to reverse split its common stock at a rate of 1 for 1,000 (the “Reverse”). Additionally, the number of common shares authorized was reduced from 2,500,000,000 to 500,000,000. On December 1, 2020, FINRA declared the Name Change and the Reverse effective.

 

On November 24, 2020, the Company amended its articles of incorporation to change its name from Quture International, Inc. to Born, Inc. (the “Name Change”). The change was made in anticipation of entering into a new line of business operations.

 

8

 

 

Also on November 24, 2020, the Company amended its articles of incorporation to reverse split its common stock at a rate of 1 for 1,000 (the “Reverse”). Additionally, the number of common shares authorized was reduced from 2,500,000,000 to 500,000,000. On December 1, 2020, FINRA declared the Name Change and the Reverse effective.

 

On February 2, 2021, the Company changed its fiscal year end to December 31.

 

On February 16, 2021, Born, Inc. (the “Company”) entered into a share exchange agreement (the “Share Exchange Agreement”) with Alkeon Creators, Inc. (“Alkeon”), a United Kingdom corporation. Under the Share Exchange Agreement, One Hundred Percent (100%) of the ownership interest of Alkeon was exchanged for 406,646,919 shares of common stock of the Company. The former stockholders of Alkeon acquired a majority of the issued and outstanding common stock as a result of the share exchange transaction.  The transaction has been accounted for as a recapitalization of the Company, whereby Alkeon is the accounting acquirer.

 

Immediately after completion of such share exchange on February 16, 2021, the Company had a total of 409,353,807 issued and outstanding shares, with authorized share capital for common share of 500,000,000.

 

The transaction with Alkeon was voided and written off in February 2021. As a result the Company was considered a dormant shell from February 2021 through July 2023 when it went into custodianship.

 

On January 14, 2024, the Eight Judicial District Court, pursuant to Case A-23-871046B issued an Order Barring Unasserted Claims against Born, Inc.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

  

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) “FASB Accounting Standard Codification™” (the “Codification”) which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States. 

 

Going Concern

 

The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these financial statements. The Company has incurred significant operating losses since inception. As of June 30, 2024 the Company had a working capital deficit of $34,227 and negative shareholders’ equity of $117,481,233.

 

Because the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing. The Company is currently being funded by David Lazar who is extending interest free demand loans to the Company. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its operations become profitable. Also, the Company has, in the past, paid for consulting services with its common stock to maximize working capital, and intends to continue this practice where feasible.

 

9

 

 

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires Management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

 

Cash and cash equivalents

 

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. On June 30, 2024, and December 31, 2023, the Company’s cash equivalents totaled $-0- and $-0- respectively.

 

Stock-based Compensation

 

The Company accounts for stock-based compensation using the fair value method following the guidance outlined in Section 718-10 of the FASB Accounting Standards Codification for disclosure about Stock-Based Compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award- the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.

 

Net Loss per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share.” Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

 

10

 

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which establishes a new lease accounting model for lessees. The updated guidance requires an entity to recognize assets and liabilities arising from financing and operating leases, along with additional qualitative and quantitative disclosures. The amended guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, with early adoption permitted. In March 2019, the FASB issued ASU 2019-01, Codification Improvements, which clarifies certain aspects of the new lease standard. The FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases in July 2018. Also in 2018, the FASB issued ASU 2018-11, Leases (Topic 842) Targeted Improvements, which provides an optional transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. The amendments have the same effective date and transition requirements as the new lease standard.

 

The Company adopted ASC 842 on July 1, 2020. The adoption of this guidance did not have any impact on the Company’s financial statements since the Company does not have any leases.

 

NOTE 3 – GOODWILL

 

On February 16, 2021, Born, Inc. the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with Alkeon Creators, Inc. (“Alkeon”), a United Kingdom corporation. Under the Share Exchange Agreement, One Hundred Percent (100%) of the ownership interest of Alkeon was exchanged for 406,646,919 shares of common stock of the Company. The former stockholders of Alkeon acquired a majority of the issued and outstanding common stock as a result of the share exchange transaction.  The transaction has been accounted for as a recapitalization of the Company, whereby Alkeon is the accounting acquirer.

 

The transaction with Alkeon was voided and written off in February 2021 and the former shareholders retained the Company shares they were issued. The fair market value of the 406,646,919 shares was determined to be $0.2101 each which was equivalent to the market price of the Born stock on the date of issuance of the shares. As a result the Company recorded a goodwill impairment of $87,670,010.

 

NOTE 4 – COMMITMENTS AND CONTINGENCIES

 

The Company did not have any contractual commitment as of June 30, 2024, and December 31, 2023.

 

NOTE 5 – NOTES PAYABLE RELATED PARTY

 

Mr. Lazar, the Company’s Court-appointed custodian is considered a related party. During the six months ended June 30, 2024, he extended $1,734 in interest free demand loans to the Company. As of June 30, 2024 the amount due to Mr. Lazar was $17,411.

  

NOTE 6 – EQUITY

 

Common stock

 

The Company has authorized 500,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock both with a par value of $0.001. As of June 30, 2024, and December 31, 2023, respectively, there were 419,984,423 and 419,984,423 shares of Common Stock issued and outstanding. Stock issued and outstanding, respectively.

 

Series A Preferred Stock

 

As of June 30, 2024 and December 31, 2023, there were 10,000,000 Series A Preferred Shares outstanding which carried super voting rights of 21,000,000,000 common shares. Each share of Preferred A is convertible into 250 shares of common stock.

 

11

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Organizational History of the Company and Overview

 

No Current Operations

 

Plan of Operation

 

The Company has no operations from a continuing business other than the expenditures related to running the Company and has no revenue from continuing operations as of the date of this Report.

 

Management intends to explore and identify business opportunities within the U.S., including a potential acquisition of an operating entity through a reverse merger, asset purchase or similar transaction. Our Chief Executive Officer has experience in business consulting, although no assurances can be given that he can identify and implement a viable business strategy or that any such strategy will result in profits. Our ability to effectively identify, develop and implement a viable plan for our business may be hindered by risks and uncertainties which are beyond our control, including without limitation, the continued negative effects of the coronavirus pandemic on the U.S. and global economies.

 

We do not currently engage in any business activities that provide revenue or cash flow. During the next 12-month period we anticipate incurring costs in connection with investigating, evaluating, and negotiating potential business combinations, filing SEC reports, and consummating an acquisition of an operating business.

 

Given our limited capital resources, we may consider a business combination with an entity which has recently commenced operations, is a developing company or is otherwise in need of additional funds for the development of new products or services or expansion into new markets or is an established business experiencing financial or operating difficulties and is in need of additional capital. Alternatively, a business combination may involve the acquisition of, or merger with, an entity which desires access to the U.S. capital markets.

 

As of the date of this Report, our management has not had any discussions with any representative of any other entity regarding a potential business combination. Any target business that is selected may be financially unstable or in the early stages of development. In such event, we expect to be subject to numerous risks inherent in the business and operations of a financially unstable or early-stage entity. In addition, we may effect a business combination with an entity in an industry characterized by a high level of risk or in which our management has limited experience, and, although our management will endeavor to evaluate the risks inherent in a particular target business, there can be no assurance that we will properly ascertain or assess all significant risks.

 

Our management anticipates that we will likely only be able to effect one business combination due to our limited capital. This lack of diversification will likely pose a substantial risk in investing in the Company for the indefinite future because it will not permit us to offset potential losses from one venture or operating territory against gains from another. The risks we face will likely be heightened to the extent we acquire a business operating in a single industry or geographical region.

 

We anticipate that the selection of a business combination will be a complex and risk-prone process. Because of general economic conditions, including unfavorable conditions caused by the coronavirus pandemic, rapid technological advances being made in some industries and shortages of available capital, management believes that there are a number of firms seeking business opportunities at this time at discounted rates with which we will compete. We expect that any potentially available business combinations may appear in a variety of different industries or regions and at various stages of development, all of which will likely render the task of comparative investigation and analysis of such business opportunities extremely difficult and complicated. Once we have developed and begun to implement our business plan, management intends to fund our working capital requirements through a combination of our existing funds and future issuances of debt or equity securities. Our working capital requirements are expected to increase in line with the implementation of a business plan and commencement of operations.

 

Based upon our current operations, we do not have sufficient working capital to fund our operations over the next 12 months. If we are able to close a reverse merger, it is likely we will need capital as a condition of closing that acquisition. Because of the uncertainties, we cannot be certain as to how much capital we need to raise or the type of securities we will be required to issue. In connection with a reverse merger, we will be required to issue a controlling block of our securities to the target’s shareholders which will be very dilutive.

 

Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences, or privileges senior to our Common Stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.

 

12

 

 

We anticipate that we will incur operating losses in the next 12 months, principally costs related to our being obligated to file reports with the SEC. Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies in their early stage of development. Such risks for us include, but are not limited to, an evolving and unpredictable business model, recognition of revenue sources, and the management of growth. To address these risks, we must, among other things, develop, implement, and successfully execute our business and marketing strategy, respond to competitive developments, and attract, retain, and motivate qualified personnel. There can be no assurance that we will be successful in addressing such risks, and the failure to do so could have a material adverse effect on our business prospects, financial condition, and results of operations.

 

Critical Accounting Policies and Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our unaudited condensed financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles, or “GAAP.” The preparation of these unaudited condensed financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and the reported amounts of revenue and expenses during the reported period. In accordance with GAAP, we base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

 

Our significant accounting policies are fully described in Note 2 to our unaudited condensed financial statements appearing elsewhere in this Quarterly Report, and we believe those accounting policies are critical to the process of making significant judgments and estimates in the preparation of our unaudited condensed financial statements.

 

Off-Balance Sheet Arrangements

 

None.

 

Item 3. Quantitative And Qualitative Disclosures About Market Risk.

 

As a smaller reporting company, we are not required to provide the information called for by this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures.

 

Our management is responsible for establishing and maintaining a system of “disclosure controls and procedures” (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management has concluded that our disclosure controls were not effective as of June 30, 2024.

 

Management’s Report on Internal Control over Financial Reporting.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

 

  pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
     
  provide reasonable assurance that transactions are recorded as necessary to permit preparation of condensed financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
     
  provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the condensed financial statements.

 

13

 

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate.

 

Our management assessed the effectiveness of our internal control over financial reporting based on the parameters set forth above and has concluded that as of June 30, 2024, our internal control over financial reporting was not effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of condensed financial statements for external purposes in accordance with U.S. generally accepted accounting principles as a result of the following material weaknesses:

 

  The Company does not have sufficient segregation of duties within accounting functions due to only having one officer and limited resources.
     
  The Company does not have an independent board of directors or an audit committee.
     
  The Company does not have written documentation of our internal control policies and procedures.
     
  All of the Company’s financial reporting is carried out by a financial consultant.

 

We plan to rectify these weaknesses by implementing an independent board of directors, establishing written policies and procedures for our internal control of financial reporting, and hiring additional accounting personnel at such time as we complete a reverse merger or similar business acquisition.

 

Changes in Internal Control over Financial Reporting.

 

There have been no change in our internal control over financial reporting during the nine months ended June 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

14

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

The Company may be involved in certain legal proceedings that arise from time to time in the ordinary course of its business. Legal expenses associated with any contingency are expensed as incurred. The Company’s officers and directors are not aware of any threatened or pending litigation to which the Company is a party or which any of its property is the subject and which would have any material, adverse effect on the Company.

 

Item 1A. Risk Factors.

 

We are a smaller reporting company and not required to include risk factor disclosures.

 

Item 2. Unregistered Sales of Equity Securities and Use Of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

   

Not applicable.

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits.

 

The following exhibits are included as part of this report:

 

Exhibit       Incorporated by Reference
Number   Exhibit Description   Form   Exhibit   Filing Date
3.1   Articles of Incorporation and Amendments, as filed with the Nevada Secretary of State.   SB-2   3.1   6/8/2007
                 
3.2   Certificates of Amendment   10-K   3.2   7/21/2020
                 
3.3   Motion for Custodianship   10-K   3.3   7/21/2020
                 
3.4   Certificate of Reinstatement   10-K   3.4   7/21/2020
                 
3.5   Bylaws   SB-2   3.2   6/8/2007
                 
31*   Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer and Chief Financial Officer.            
                 
32*   Rule 1350 Certifications of Chief Executive Officer and Chief Financial Officer.            
                 
101.INS*   XBRL Instance Document.            
                 
101.SCH*   XBRL Taxonomy Extension Schema Document.            
                 
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document.            
                 
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document.            
                 
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document.            
                 
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document.            
                 
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).            

 

* Filed herewith.

 

15

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BORN, INC.
     
Dated: January 13, 2025 By: /s/ David Lazar
    David Lazar
   

Chief Executive Officer and
Chief Financial Officer

Principal Executive Officer,
Principal Financial Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

16

 

BYRN INC. false --12-31 Q2 0001397795 0001397795 2024-01-01 2024-06-30 0001397795 2025-01-13 0001397795 2024-06-30 0001397795 2023-12-31 0001397795 us-gaap:RelatedPartyMember 2024-06-30 0001397795 us-gaap:RelatedPartyMember 2023-12-31 0001397795 2024-04-01 2024-06-30 0001397795 2023-04-01 2023-06-30 0001397795 2023-01-01 2023-06-30 0001397795 us-gaap:PreferredStockMember 2022-12-31 0001397795 us-gaap:CommonStockMember 2022-12-31 0001397795 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001397795 us-gaap:RetainedEarningsMember 2022-12-31 0001397795 2022-12-31 0001397795 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001397795 2023-01-01 2023-03-31 0001397795 us-gaap:PreferredStockMember 2023-03-31 0001397795 us-gaap:CommonStockMember 2023-03-31 0001397795 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001397795 us-gaap:RetainedEarningsMember 2023-03-31 0001397795 2023-03-31 0001397795 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001397795 us-gaap:PreferredStockMember 2023-06-30 0001397795 us-gaap:CommonStockMember 2023-06-30 0001397795 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001397795 us-gaap:RetainedEarningsMember 2023-06-30 0001397795 2023-06-30 0001397795 us-gaap:PreferredStockMember 2023-12-31 0001397795 us-gaap:CommonStockMember 2023-12-31 0001397795 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001397795 us-gaap:RetainedEarningsMember 2023-12-31 0001397795 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001397795 2024-01-01 2024-03-31 0001397795 us-gaap:PreferredStockMember 2024-03-31 0001397795 us-gaap:CommonStockMember 2024-03-31 0001397795 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001397795 us-gaap:RetainedEarningsMember 2024-03-31 0001397795 2024-03-31 0001397795 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001397795 us-gaap:PreferredStockMember 2024-06-30 0001397795 us-gaap:CommonStockMember 2024-06-30 0001397795 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001397795 us-gaap:RetainedEarningsMember 2024-06-30 0001397795 srt:MinimumMember 2011-08-10 2011-08-10 0001397795 srt:MaximumMember 2011-08-10 2011-08-10 0001397795 2011-08-10 0001397795 us-gaap:CommonStockMember 2011-08-10 0001397795 brrn:BlankCheckPreferredStockMember 2011-08-10 0001397795 brrn:MrLazarMember 2020-04-05 0001397795 brrn:MrLazarMember 2020-04-05 2020-04-05 0001397795 brrn:MrLazarMember 2020-09-10 0001397795 us-gaap:SeriesAPreferredStockMember 2020-09-10 2020-09-10 0001397795 brrn:SeriesAConvertiblePreferredStockMember 2020-09-23 0001397795 brrn:CustodianVenturesLLCMember 2020-09-23 0001397795 us-gaap:CommonStockMember 2020-11-24 2020-11-24 0001397795 srt:MinimumMember 2020-11-24 0001397795 srt:MaximumMember 2020-11-24 0001397795 2020-11-24 2020-11-24 0001397795 brrn:AlkeonCreatorsIncMember 2021-02-16 0001397795 2021-02-16 0001397795 us-gaap:CommonStockMember 2021-02-16 0001397795 brrn:AlkeonCreatorsIncMember 2021-02-16 0001397795 us-gaap:RelatedPartyMember 2024-01-01 2024-06-30 0001397795 us-gaap:SeriesAPreferredStockMember 2024-06-30 0001397795 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001397795 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-12-31 0001397795 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001397795 us-gaap:CommonStockMember 2024-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure